Perpetual Industries Inc. (OTC:PRPI) Stock In Focus After Reorganization Plans and Director Resignations

October 28, 2024

This past Friday, the Perpetual Industries Inc. (OTC:PRPI) stock had been in focus among investors, and the situation could well remain the same this morning as investors return to trade. Let’s take a closer look at the developments from October 25 to have a better idea. Major Announcement Last Friday, the company hit the newswires after it announced a strategic reorganization of its subsidiary unit Worldwide Auctioneers in the collector…

Read More >>

Petros Pharmaceuticals Inc. (NASDAQ: PRPI) Conducting Stendra Pilot Study Seeking OTC status from the FDA

July 28, 2021

Petros Pharmaceuticals Inc. (NASDAQ: PRPI)  has completed a small pilot label comprehension study which is the first step in the process of obtaining an over-the-counter starter for its erectile dysfunction drug, Stendra, from the US FDA.   Stendra is in the process to receive OTC status Stendra has FDA approval as an oral phosphodiesterase 5 (PDE5) prescription inhibitor for erectile dysfunction treatment.  Chief commercial officer Fady Boctor said there is an…

Read More >>